ITRE reaches agreement on FP7

The European Parliament's Industry, Research and Energy Committee (ITRE) has adopted, in a second reading, a set of comprise amendments on the Seventh Framework Programme (FP7), which were agreed upon in informal meetings with the Council.

The 39 new amendments deal with issues such as the structure of the European Research Council (ERC) and the proposed Risk Sharing Finance Facility (RSFF).

MEPs agreed on an amendment on renewable and end use energy, which foresees a 'major part' of the budget from FP7's energy theme going to the field, instead of two thirds as proposed by the Parliament in its first reading. According to ITRE, special attention will be devoted to the coordination of issues linked to rational and efficient use of energy in FP7 and in other EU policies.

A compromise was also reached regarding the administrative costs of the ERC, which should now not exceed 5% - MEPs had originally asked for a limit of 3%. On the issue of the Parliament's involvement in the interim evaluation of the ERC, it was agreed to opt for co-decision procedure in case changes in the structure of ERC become necessary.

ITRE also endorsed amendments on the rules of participation for companies, research centres and universities, as well as the RSFF, which is designed to encourage bank lending to research projects. Initially, the Council had planned to allocate €1 billion from the FP7 budget to finance RSFF. However, under the amendment, a lower contribution of €500 million is foreseen until 2010, with the possibility of releasing the additional €500 million after a review.

On the European Institute of Technology (EIT), the committee stressed that no money from FP7 should be used to finance the proposed structure. Only administrative costs directly associated with research projects may be covered.

The amended text will be put to the vote at a Parliament plenary session, due to be held on 29 November, before it is put to the Council on 5 December.

If all goes to plan, the first calls for proposals for FP7 projects could be published by December 2006, with closing dates in March 2007. Following an evaluation period, the first FP7 projects could start as early as the end of 2007 or early 2008

For further information on FP7, please visit:
http://cordis.europa.eu/fp7/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...